The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

One of the most common side effects of blood thinners ... Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn Schmiedebergs ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

Ketamine, a hallucinogenic drug approved as an anesthetic, has been used to treat adults with depression, PTSD and other ...

Strokes are life-altering events that can profoundly impact both body and mind. One of the most challenging consequences for survivors is the loss of ...

Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression ... being one of the most common residual symptoms ...

20, 2024 — Depression is one of the most common mental illnesses ... Multiple Sclerosis Drug May Help With Poor Working Memory Nov. 18, 2024 — Fampridine is currently used to improve walking ...

meta-analyses and practical clinical studies have found that only a third of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant ...

In a statement, Neumora revealed that the KOASTAL-1 study missed its primary endpoint, with navacaprant failing to achieve a ...

23, 2024 — The standard medication levodopa does not ... Nov. 20, 2024 — Depression is one of the most common mental illnesses. As many as 280 million people worldwide are affected by this ...